Recent Updates
Recently added Catalysts
KNSA Positive Sentiment

Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London

Key Takeaway: Kiniksa Pharmaceuticals will participate in a fireside chat at the Jefferies Global Healthcare Conference on November 16, 2026. The presentation will be available via live webcast and a replay will be accessible shortly after. Kiniksa aims to develop novel therapies for patients with unmet medical needs, particularly in cardiovascular indications.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kiniksa will present at a major healthcare conference.
  • The event will be accessible via a live webcast.
  • The company focuses on unmet medical needs in cardiovascular diseases.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+91%
120-day peak, hindsight
Typical move
11.6%
average across 3 past catalysts
Lead asset
mavrilimumab
Phase 3 · COVID

Full Press Release Details

LONDON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026 at 11:00 a.m. Greenwich Mean Time (6:00 a.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ®

Kiniksa Investor & Media Contact Jonathan Kirshenbaum (781) 829-3949 jkirshenbaum@kiniksa.com

Frequently Asked Questions

When will Kiniksa present at the conference?

Kiniksa will present on November 16, 2026, at 11:00 a.m. GMT.

How can I watch Kiniksa's presentation?

The presentation will be available via live webcast on Kiniksa's website.

What is Kiniksa's focus in biopharmaceuticals?

Kiniksa focuses on developing therapies for unmet needs in cardiovascular diseases.

Will there be a replay of the presentation?

Yes, a replay will be available on Kiniksa's website within 48 hours.

Last updated: Nov 11, 2026